MedPath

Delivering an individualised web-based exercise intervention to support individuals with metastatic prostate cancer: A pilot randomised control trial

Not Applicable
Recruiting
Conditions
Metastatic Prostate Cancer
Cancer - Prostate
Registration Number
ACTRN12618001979246
Lead Sponsor
The University of Adelaide
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
66
Inclusion Criteria

To be eligible, participants must be living with metastatic prostate cancer. They need to have access to a computer with the internet and be able to read and write in English. Lastly, they need to have consent from their physician with a note from their physician detailing the extent and location of metastases.

Exclusion Criteria

Patients will be ineligible if they have any contraindications to performing moderate physical activity (resistance, aerobic and flexibility) for at least 20 minutes, up to two days of the week. This includes no recent serious cardiovascular events (within 12?months, including but not limited to, unstable bone metastases, spinal compressions, transient ischaemic attack, cerebrovascular accident or myocardial infarction), acute pulmonary embolus or infarction, acute myocarditis or pericarditis, aneurysm or an acute infection. Participants will also be excluded from the study if they are already participating in two sessions of resistance-training and 60 minutes of structured moderate-vigorous aerobic exercise per week (participants meeting one target but not the other will be eligible).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath